Bellerophon Therapeutics Stock (OTC: BLPH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 45.197K |
Day Range | - - - |
52 Wk Range | 0.029 - 11.150 |
Market Cap | $440.375K |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bellerophon Therapeutics (OTCPK: BLPH) through any online brokerage.
There are no as such competitors for Bellerophon Therapeutics.
The latest price target for Bellerophon Therapeutics (OTCPK: BLPH) was reported by HC Wainwright & Co. on Tuesday, June 6, 2023. The analyst firm set a price target for 2.00 expecting BLPH to rise to within 12 months (a possible 5455.56% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Bellerophon Therapeutics (OTCPK: BLPH) is $0.036 last updated November 13, 2023 at 8:01 AM EST.
There are no upcoming dividends for Bellerophon Therapeutics.
Bellerophon Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Bellerophon Therapeutics.
Bellerophon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.